medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2015-11-80-83medsovet-296Research ArticleГИНЕКОЛОГИЯGYNECOLOGYБактериальный вагиноз: современный взгляд на проблемуBacterial vaginosis: a modern view of the problemМурашкоА. В.MurashkoMD, Prof.noemail@neicon.ruМурашкоА. А.MurashkoA. A.noemail@neicon.ruПервый Московский государственный медицинский университет им. И.М. Сеченова Минздрава РоссииРоссияFirst Moscow State Medical University named after I.M. Sechenov, Russia’s Ministry of HealthRussian Federation2015301220150118083Copyright © Мурашко А.В., Мурашко А.А., 20152015Мурашко А.В., Мурашко А.А.Murashko M.P., Murashko A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/296

Бактериальный вагиноз (БВ) - одна из наиболее распространенных инфекционных патологий женщин детородного возраста. Бактериальный вагиноз - это состояние, при котором нормальная микрофлора влагалища, представленная в основном лактобактериями, заменяется многочисленной анаэробной и другой условно-патогенной флорой. Установлена связь дисбактериоза с такими осложнениями, как разрыв плодных оболочек, преждевременные роды, инфекции хориона, амниона, околоплодных вод, внутриутробная гибель плода. Это говорит о необходимости проведения скрининга бактериального вагиноза и его лечения до наступления беременности.

Bacterial vaginosis (BV) is one of the most common infectious pathologies in women of childbearing age. Bacterial vaginosis is a condition in which the normal vaginal flora represented mostly by lactobacilli is invaded by anaerobic and other opportunistic flora. There is a relationship between dysbacteriosis and complications such as rupture of membranes, premature delivery, infection of the chorion, amnion, amniotic fluid, and intrauterine fetal death. This suggests the need for screening for bacterial vaginosis and its treatment before pregnancy.

бактериальный вагинозмикрофлора лактобактериидиагностикалечениеbacterial vaginosismicrofloralactobacillidiagnosistreatmentReferencesГродницкая Е.Э. Микробиоценоз влагалища и пути его коррекции у женщин с самопроизвольным прерыванием беременности в поздние сроки гестации в анамнезе. Российский вестник акушера-гинеколога, 2011. 1.Гродницкая Е.Э. Микробиоценоз влагалища и пути его коррекции у женщин с самопроизвольным прерыванием беременности в поздние сроки гестации в анамнезе. Российский вестник акушера-гинеколога, 2011. 1.Карапетян Т.Э. Значение оппортунистической инфекции влагалища в развитии внутриутробной инфекции плода и новорожденного (ретроспективное исследование). Акушерство и гинекология, 2010. 4: 59-63.Карапетян Т.Э. Значение оппортунистической инфекции влагалища в развитии внутриутробной инфекции плода и новорожденного (ретроспективное исследование). Акушерство и гинекология, 2010. 4: 59-63.Кира Е.Ф. Современные подходы к выбору препарата локального действия в терапии бактериального вагиноза. Акушерство и гинекология, 2012. 7: 59-66.Кира Е.Ф. Современные подходы к выбору препарата локального действия в терапии бактериального вагиноза. Акушерство и гинекология, 2012. 7: 59-66.Trama JP, Pascal KE, Zimmerman J, Self MJ, Mordechai E, Adelson ME. Rapid detection of Atopobium vaginae and association with organisms implicated in bacterial vaginosis. Mol Cell Probes, 2008. 22: 96-102.Trama JP, Pascal KE, Zimmerman J, Self MJ, Mordechai E, Adelson ME. Rapid detection of Atopobium vaginae and association with organisms implicated in bacterial vaginosis. Mol Cell Probes, 2008. 22: 96-102.Ling Z, Kong J, Liu F, Zhu H, Chen X, Wang Y et al. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genom, 2010. 11: 488.Ling Z, Kong J, Liu F, Zhu H, Chen X, Wang Y et al. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genom, 2010. 11: 488.Кира Е.Ф. Нетрансмиссивные инфекции -новые болезни цивилизации? Акушерство и гинекология, 2008. 5: 61-66.Кира Е.Ф. Нетрансмиссивные инфекции -новые болезни цивилизации? Акушерство и гинекология, 2008. 5: 61-66.Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol, 2007. 109: 114-120.Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol, 2007. 109: 114-120.Кулаков В.И. Практическая гинекология: клинические лекции / под ред. акад. РАМН В.И. Кулакова, проф. В.Н. Прилепской. 4-е изд., доп. М.: МЕД- пресс-информ, 2008. 752 с.Кулаков В.И. Практическая гинекология: клинические лекции / под ред. акад. РАМН В.И. Кулакова, проф. В.Н. Прилепской. 4-е изд., доп. М.: МЕД- пресс-информ, 2008. 752 с.Ryckman KK, Simhan HN, Krohn MA, Williams SM. Predicting risk of bacterial vaginosis: The role of race, smoking and corticotropin-releasing hormone-related genes. Mol Hum Reprod, 2009. 15: 31-7.Ryckman KK, Simhan HN, Krohn MA, Williams SM. Predicting risk of bacterial vaginosis: The role of race, smoking and corticotropin-releasing hormone-related genes. Mol Hum Reprod, 2009. 15: 31-7.Hickey RJ, Zhou X, Pierson JD, Ravel J, Forney LJ. Understanding vaginal microbiome complexity from an ecological perspective. Transl Res, 2012.160: 267-282.Hickey RJ, Zhou X, Pierson JD, Ravel J, Forney LJ. Understanding vaginal microbiome complexity from an ecological perspective. Transl Res, 2012.160: 267-282.Nam H, Whang K, Lee Y. Analysis of vaginal lactic acid producing bacteria in healthy women. J Microbiol, 2007. 45: 515-20.Nam H, Whang K, Lee Y. Analysis of vaginal lactic acid producing bacteria in healthy women. J Microbiol, 2007. 45: 515-20.Hil lier S. The complexity of microbial diversity in bacterial vaginosis. N Eng J Med, 2005. 353: 1886-7.Hil lier S. The complexity of microbial diversity in bacterial vaginosis. N Eng J Med, 2005. 353: 1886-7.Menard JP, Fenollar F, Henry M, Bretelle F, Raoult D. Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin. Infect. Dis., 2008. 47: 33-43.Menard JP, Fenollar F, Henry M, Bretelle F, Raoult D. Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin. Infect. Dis., 2008. 47: 33-43.Darw i sh A, Elnshar EM, Hamadeh SM, Makarem MH. Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes. J Obstet Gynaecol Res., 2007. 33: 781-7.Darw i sh A, Elnshar EM, Hamadeh SM, Makarem MH. Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes. J Obstet Gynaecol Res., 2007. 33: 781-7.Ворошилина Е.С. Современные возможности диагностики бактериального вагиноза: исследование количественного и качественного состава сложных микробных сообществ. Микробиология, 2011. 13: 70-74.Ворошилина Е.С. Современные возможности диагностики бактериального вагиноза: исследование количественного и качественного состава сложных микробных сообществ. Микробиология, 2011. 13: 70-74.Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med, 1983. 74: 14-22.Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med, 1983. 74: 14-22.Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med, 2005. 353: 1899-911.Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med, 2005. 353: 1899-911.Livengood CH. Bacterial vaginosis: an overview for 2009. Rev Obstet Gynecol, 2009. 2: 28-37.Livengood CH. Bacterial vaginosis: an overview for 2009. Rev Obstet Gynecol, 2009. 2: 28-37.Donati L, Di Vico A, Nucci M, Ouagliozzi L, Spagnuolo T, Labianca A, Bracaglia M, lanniello F, Caruso A, Paradisi G. Vaginal microbial flora and outcome of pregnancy. Arch Gynecol Obstet, 2010. 281: 589-600.Donati L, Di Vico A, Nucci M, Ouagliozzi L, Spagnuolo T, Labianca A, Bracaglia M, lanniello F, Caruso A, Paradisi G. Vaginal microbial flora and outcome of pregnancy. Arch Gynecol Obstet, 2010. 281: 589-600.Mitchell CM, Hitti JE, Agnew KJ, Fredricks DN. Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: Impact on fastidious bacteria. BMC Infect Dis, 2009. 9: 89.Mitchell CM, Hitti JE, Agnew KJ, Fredricks DN. Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: Impact on fastidious bacteria. BMC Infect Dis, 2009. 9: 89.Dickey LJ, Nailor MD, Sobel JD. Guidelines for the treatment of bacterial vaginosis: Focus on tinidazole. Ther Clin Risk Manag, 2009. 5: 485-9.Dickey LJ, Nailor MD, Sobel JD. Guidelines for the treatment of bacterial vaginosis: Focus on tinidazole. Ther Clin Risk Manag, 2009. 5: 485-9.Decena DC, Co JT, Manalastas RM, Jr, Palaypayon EP, Padolina CS, Sison JM, et al. Metronidazole with Lactacyd vaginal gel in bacterial vaginosis. J Obstet Gynaecol Res, 2006. 32: 243-51.Decena DC, Co JT, Manalastas RM, Jr, Palaypayon EP, Padolina CS, Sison JM, et al. Metronidazole with Lactacyd vaginal gel in bacterial vaginosis. J Obstet Gynaecol Res, 2006. 32: 243-51.Schwebke JR, Desmond RA. Tinidazole vs metronidazole for the treatment of bacterial vaginosis. Am J Obstet Gynecol, 2011. 204: 211.e1-e6.Schwebke JR, Desmond RA. Tinidazole vs metronidazole for the treatment of bacterial vaginosis. Am J Obstet Gynecol, 2011. 204: 211.e1-e6.Anukam K, Reid G. Probiotics: 100 years (19072007) after Elie Metchnikoffs Observation. Kingsley C Anukam, 2008: 21.Anukam K, Reid G. Probiotics: 100 years (19072007) after Elie Metchnikoffs Observation. Kingsley C Anukam, 2008: 21.Delia A, Morgante G, Rago G, Musacchio MC, Petraglia F, De Leo V. Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis. Minerva Ginecol, 2006. 58: 227-31.Delia A, Morgante G, Rago G, Musacchio MC, Petraglia F, De Leo V. Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis. Minerva Ginecol, 2006. 58: 227-31.Mclean N, Rosenstein IJ. Characterisation and selection of a Lactobacillus species to recolo-nise the vagina of women with recurrent bacterial vaginosis. J Med Microbio, 2000. 49: 543-52.Mclean N, Rosenstein IJ. Characterisation and selection of a Lactobacillus species to recolo-nise the vagina of women with recurrent bacterial vaginosis. J Med Microbio, 2000. 49: 543-52.Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microb Infect, 2006. 8: 1450-4.Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microb Infect, 2006. 8: 1450-4.Martinez RC, Franceschini SA, Patta MC, et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol, 2009. 55: 133-138.Martinez RC, Franceschini SA, Patta MC, et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol, 2009. 55: 133-138.Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vagino-sis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health, 2008. 8: 3.Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vagino-sis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health, 2008. 8: 3.Holley RL, Richter HE, Varner RE, Pair L, Schwebke JR. A randomized, double-blind clinical trial of vaginal acidification versus placebo for the treatment of symptomatic bacterial vaginosis. Sex Transm Dis, 2004. 31: 236-238.Holley RL, Richter HE, Varner RE, Pair L, Schwebke JR. A randomized, double-blind clinical trial of vaginal acidification versus placebo for the treatment of symptomatic bacterial vaginosis. Sex Transm Dis, 2004. 31: 236-238.Simoes JA, Bahamondes LG, Camargo RP et al. A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br J Clin Pharmacol, 2006. 61: 211-217.Simoes JA, Bahamondes LG, Camargo RP et al. A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br J Clin Pharmacol, 2006. 61: 211-217.

The authors declare that there are no conflicts of interest present.